David A. Siegel Bio Rad Laboratories, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 10,900 shares of BIO stock, worth $3.58 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,900

Previous 14,868 26.69%

Holding current value

$3.58 Million

Previous $4.06 Million 10.2%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$263.97 - $344.64 $1.05 Million - $1.37 Million	-3,968 Reduced 26.69%	10,900 $3.65 Million
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $616,998 - $780,804	-2,300 Reduced 13.4%	14,868 $4.06 Million
Q1 2024 May 15, 2024	SELL	$304.11 - $351.99 $1.16 Million - $1.34 Million	-3,800 Reduced 18.12%	17,168 $5.94 Million
Q4 2023 Feb 14, 2024	SELL	$269.37 - $365.04 $8.57 Million - $11.6 Million	-31,800 Reduced 60.26%	20,968 $6.77 Million
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $245,175 - $295,841	700 Added 1.34%	52,768 $18.9 Million
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $1.15 Million - $1.56 Million	3,200 Added 6.55%	52,068 $19.7 Million
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $6.03 Million - $7.24 Million	-14,400 Reduced 22.76%	48,868 $23.4 Million
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $3.94 Million - $5.11 Million	11,200 Added 21.51%	63,268 $26.6 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $2.85 Million - $3.89 Million	6,900 Added 15.28%	52,068 $21.7 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $2.85 Million - $3.89 Million	6,900 Added 15.28%	52,068 $21.7 Million
Q2 2022 Aug 15, 2022	BUY	$463.67 - $597.16 $4.54 Million - $5.85 Million	9,800 Added 27.71%	45,168 $22.4 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $9.76 Million - $13.7 Million	18,600 Added 110.93%	35,368 $19.9 Million
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $10.8 Million - $12.1 Million	15,200 Added 969.39%	16,768 $12.7 Million
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $789,252 - $990,924	1,200 Added 326.09%	1,568 $1.17 Million
Q2 2021 Aug 16, 2021	SELL	$576.64 - $649.04 $288,320 - $324,520	-500 Reduced 57.6%	368 $237,000
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $474,804 - $574,919	868 New	868 $496,000
Q3 2020 Nov 16, 2020	SELL	$454.43 - $535.6 $9.44 Million - $11.1 Million	-20,765 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$334.87 - $493.06 $9.78 Million - $14.4 Million	-29,200 Reduced 58.44%	20,765 $9.38 Million
Q1 2020 May 15, 2020	SELL	$320.01 - $409.07 $16.2 Million - $20.7 Million	-50,500 Reduced 50.27%	49,965 $17.5 Million
Q4 2019 Feb 14, 2020	BUY	$319.73 - $374.2 $415,649 - $486,460	1,300 Added 1.31%	100,465 $37.2 Million
Q3 2019 Nov 14, 2019	BUY	$304.55 - $345.24 $10.3 Million - $11.7 Million	33,900 Added 51.94%	99,165 $33 Million
Q2 2019 Aug 14, 2019	SELL	$286.93 - $312.59 $1.46 Million - $1.59 Million	-5,100 Reduced 7.25%	65,265 $20.4 Million
Q1 2019 May 15, 2019	BUY	$224.3 - $317.41 $14 Million - $19.8 Million	62,500 Added 794.66%	70,365 $21.5 Million
Q4 2018 Feb 14, 2019	SELL	$220.1 - $309.0 $638,290 - $896,100	-2,900 Reduced 26.94%	7,865 $1.83 Million
Q3 2018 Nov 14, 2018	BUY	$289.28 - $326.15 $202,495 - $228,304	700 Added 6.95%	10,765 $3.37 Million
Q2 2018 Aug 14, 2018	BUY	$244.1 - $303.88 $366,150 - $455,820	1,500 Added 17.51%	10,065 $2.9 Million
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $3.23 Million - $3.78 Million	-13,800 Reduced 61.7%	8,565 $2.14 Million
Q4 2017 Feb 14, 2018	BUY	$216.94 - $271.3 $4.08 Million - $5.1 Million	18,800 Added 527.35%	22,365 $5.34 Million
Q3 2017 Nov 14, 2017	BUY	$212.27 - $242.28 $756,742 - $863,728	3,565	3,565 $792,000

Others Institutions Holding BIO

# of Institutions

456

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.09B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account